Through years of scientific and clinical exposure across both human and veterinary medicine, CaniCatiCare Inc. (CCC), a pet precision medicine company, has recognized a persistent distance between the pace of innovation in human healthcare and the way comparable advances reach companion animals. "Human medicine keeps pushing forward with data-driven tests and personalized treatments, while animal healthcare has taken its own route, shaped by different needs and tools," Jaewoo Hong, DVM, founder of CCC and professor at Daegu Catholic University School of Medicine, says. The company aims to serve as a bridge, adapting proven human medical science into tools for veterinary care.
Looking across the broader healthcare landscape, this gap is neither abstract nor theoretical. In human cancer care, precision medicine has evolved to use patient‑specific genetic and molecular information to guide diagnosis and treatment decisions. These insights help clinicians select therapies with a clearer understanding of how a disease may behave. "In veterinary medicine, the science was limited. The problem was the infrastructure around it. We've long understood the biology; what we lacked were tools built specifically for animals," Hong states.
